Reporting owner · CIK 0001723524
Sherman Darren
SEC Form 4 history across 1 companies, 5 transactions and 4 filings.
SRSee RemarksOrchestra BioMed Holdings, Inc.
Open-market transaction mix33% buys1 buys · 2 sales
Available history · May 28, 2026 – Oct 01, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
OBIOOrchestra BioMed Holdings, Inc. | Sherman DarrenSR | S · sale10b5-1 detectedSEC filing ↗ | -$95.4kView disclosure → | |
OBIOOrchestra BioMed Holdings, Inc. | Sherman DarrenSR | S · sale10b5-1 detectedSEC filing ↗ | -$74.1kView disclosure → | |
OBIOOrchestra BioMed Holdings, Inc. | Sherman DarrenSR | P · buySEC filing ↗ | $10.6kView disclosure → | |
OBIOOrchestra BioMed Holdings, Inc. | Sherman DarrenSR | F · withholdingSEC filing ↗ | -$25.9kView disclosure → | |
OBIOOrchestra BioMed Holdings, Inc. | Sherman DarrenSR | F · withholdingSEC filing ↗ | -$19.6kView disclosure → |
Latest Form 4 facts
Quick context from source filings
Latest open-market transaction
sale at Orchestra BioMed Holdings, Inc. on Oct 01, 2026 valued at $95,400.
Review SEC filingLatest buy
buy at Orchestra BioMed Holdings, Inc. on Aug 26, 2026 valued at $10,660.
Review SEC filingLatest sale
sale at Orchestra BioMed Holdings, Inc. on Oct 01, 2026 valued at $95,400.
Review SEC filingMonthly open-market activity
Last 4 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| May 2026 | 0 | 0 | $0.00 | $0.00 | $0.00 |
| Aug 2026 | 1 | 0 | $10,660.00 | $0.00 | $10,660.00 |
| Sep 2026 | 0 | 1 | $0.00 | $74,100.00 | -$74,100.00 |
| Oct 2026 | 0 | 1 | $0.00 | $95,400.00 | -$95,400.00 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Average P/S size$60.1K
Median P/S size$74.1K
Direct4
Indirect1
Oct 01, 2026sale
Filing-only signals
Deterministic matches in this insider's history
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
Forward return is not available yet
No purchases currently have the price observations needed for a 90-day return. This may reflect incomplete price coverage or purchases that have not reached the return window.
Disclosed ownership
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
3 observations · Aug 26, 2026 – Oct 1, 2026. Window ends at the latest available report, not today.
Selected observation · Oct 1, 20261,119,402 shares reported
Inspect transaction View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| Aug 26, 2026 | 1,149,402 | Aug 28, 2026 | View transaction |
| Sep 1, 2026 | 1,134,402 | Sep 2, 2026 | View transaction |
| Oct 1, 2026 | 1,119,402 | Oct 2, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Sherman Darren Insider Activity FAQ
SEC Form 4 context
Who is Sherman Darren?
Sherman Darren is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001723524.
Which companies has Sherman Darren reported transactions for?
Orchestra BioMed Holdings, Inc.
When was Sherman Darren's latest insider buy?
buy at Orchestra BioMed Holdings, Inc. on Aug 26, 2026 valued at $10,660.
When was Sherman Darren's latest insider sale?
sale at Orchestra BioMed Holdings, Inc. on Oct 01, 2026 valued at $95,400.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.